News | Contrast Media | October 10, 2017

Guerbet to Participate in French Interventional Radiology Conference

Company will organize pair of symposiums and present mixing and injection system for conventional trans-arterial chemoembolization

Guerbet to Participate in French Interventional Radiology Conference

October 10, 2017 — Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will be held in Paris, France, Oct. 13-16, 2017.

The JFR, a major international gathering for medical imaging players, annually brings together more than 17,000 diagnostic and interventional radiology experts from France and abroad. This year, the JFR, a place for discussion and debate focusing on innovation, research and development, will place emphasis on the theme "Patients and their Radiologists."

Guerbet will present its integrated magnetic resonance imaging (MRI) and scanner offers as well as its digital solutions. For the sixth consecutive year, Guerbet will also be an exhibitor and partner of the "Interventional Radiology Village" where, for the first time, it will present Vectorio, its conventional trans-arterial chemo-embolization (cTACE) mixing and injection device that obtained the CE mark in September 2017. Vectorio encompasses a set of medical devices that are resistant to Lipiodol Ultra Fluide, used for cTACE

Guerbet will also organize two symposiums during the JFR:

  • "Gadolinium deposits in the brain: what is the current situation?" Friday, Oct. 13 — Prof. Fabrice Bonneville (Toulouse University Hospital) will be the moderator and findings will be presented by Prof. Douraied Ben Salem (Brest University Hospital), Dr. Nicolas Menjot De Champfleur (Montpellier University Hospital), Prof. François Cotton (Lyon Public Hospital) and Prof. Isabelle Thomassin (Tenon Public Hospital, Paris).
  • "Guerbet, the present and future in interventional radiology" Saturday, Oct. 14 — Prof. Afshin Gangi (Strasbourg University Hospital) will be the moderator and Prof. Jean-Pierre Pelage (Caen University Hospital), Prof. Patrick Chevallier (Nice University Hospital) and Prof. Romaric Loffroy (Dijon University hospital) will all present their work.

For more information: www.guerbet.com

Related Content

News | Contrast Media | November 14, 2018
Voyageur Minerals Ltd. signed a joint venture agreement with Chief Medical Supply Ltd (CM) of Calgary, Alberta to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.